Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 6/20 | 0.54 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | TERT | O14746 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | BLM | P54132 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | FABP4 | P15090 | 2/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | PPARG | P37231 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | PPARD | Q03181 | 2/20 | 0.46 |
| ▸ | PPARA | Q07869 | 2/20 | 0.46 |
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL448357 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL129511 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL448718 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL450997 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL10959408 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL9366273 | 1.00 | — | — | |
| SCHEMBL135854 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL9362653 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL10959317 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL10955670 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1414873-B1 | ENHANCED POLYMERIZATION PROCESS | SABIC INNOVATIVE PLASTICS IP (NL) | 2008-12-03 | — | — | EP | claimed |
| EP-1200496-B1 | PROCESS FOR THE MANUFACTURE OF IMPACT RESISTANT MODIFIED POLYMERS | BAYER AG (US) | 2004-03-10 | — | — | EP | claimed |
| CN-111748349-A | Quantum dot and manufacturing method thereof | 拓米(成都)应用技术研究院有限公司 | 2020-10-09 | — | — | CN | disclosed |
| EP-3090000-B1 | HYDROGENATED NITRILE RUBBER CONTAINING PHOSPHINE OR DIPHOSPHANE OXIDE | ARLANXEO DEUTSCHLAND GMBH (DE) | 2019-10-02 | — | — | EP | disclosed |
| EP-3090002-B1 | HYDROGENATED NITRILE RUBBER CONTAINING PHOSPHINE OR DIPHOSPHANE OXIDE | ARLANXEO DEUTSCHLAND GMBH (DE) | 2019-10-02 | — | — | EP | disclosed |
| EP-2883865-B1 | Compound capable of binding S1P receptor and pharmaceutical use thereof | ONO PHARMACEUTICAL CO (JP) | 2019-09-25 | — | — | EP | disclosed |
| EP-3283538-B1 | POWDER FORM MIXTURES CONTAINING LOW-EMISSION NITRILE RUBBERS | ARLANXEO DEUTSCHLAND GMBH (DE) | 2019-06-19 | — | — | EP | disclosed |
| EP-3283538-A1 | PULVERULENT MIXTURES CONTAINING LOW-EMISSION NITRILE RUBBERS | ARLANXEO Deutschland GmbH (DE) | 2018-02-21 | — | — | EP | disclosed |
| EP-2860197-B1 | Nitrile rubbers with low emissions | ARLANXEO DEUTSCHLAND GMBH (DE) | 2017-04-19 | — | — | EP | disclosed |
| EP-2162430-B1 | MERCAPTAN MIXTURE | ARLANXEO DEUTSCHLAND GMBH (DE) | 2016-11-30 | — | — | EP | disclosed |
| EP-3090002-A1 | HYDROGENATED NITRILE RUBBER CONTAINING PHOSPHINE OXIDE OR DIPHOSPHINE OXIDE | ARLANXEO Deutschland GmbH (DE) | 2016-11-09 | — | — | EP | disclosed |
| US-20040259877-A1 | Inhibitors against the production and release of inflammatory cytokines | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2004-12-23 | — | — | US | disclosed |
| EP-1352650-A1 | INHIBITORS AGAINST THE PRODUCTION AND RELEASE OF INFLAMMATORY CYTOKINES | Institute of Medicinal Molecular Design, Inc. (JP) | 2003-10-15 | — | — | EP | disclosed |
| EP-0694337-B1 | Method for reducing microfoam in a spray-applied waterborne thermoset composition | ROHM & HAAS (US) | 1999-02-10 | — | — | EP | disclosed |
| EP-0694337-A1 | Method for reducing microfoam in a spray-applied waterborne thermoset composition | ROHM AND HAAS COMPANY (US) | 1996-01-31 | — | — | EP | disclosed |
| EP-0354460-B1 | Process to produce organosulfur compounds | PHILLIPS PETROLEUM CO (US) | 1994-04-13 | — | — | EP | disclosed |
| EP-0354460-A1 | Process to produce organosulfur compounds | PHILLIPS PETROLEUM COMPANY (US) | 1990-02-14 | — | — | EP | disclosed |
| EP-0243016-B1 | N, S CONTAINING CORROSION INHIBITORS | EXXON CHEMICAL PATENTS INC. (US) | 1989-12-06 | — | — | EP | disclosed |
| EP-0243016-A1 | N, S containing corrosion inhibitors | EXXON CHEMICAL PATENTS INC. (US) | 1987-10-28 | — | — | EP | disclosed |
| US-4673436-A | THIO SUBSTITUTED QUATERNARY AMMONIUM SALTA | EXXON CHEMICAL PATENTS INC. (US) | 1987-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040259877-A1 | Inhibitors against the production and release of inflammatory cytokines | NFKBIA, IL1B, IKBKB | FAAH 1462/4885TRPV1 1398/4885TSHR 4035/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.